A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim
Authors
Keywords
Physiologically based pharmacokinetic modelling, PBPK, Therapeutic proteins, Antibodies, Biologics
Journal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Volume 45, Issue 2, Pages 235-257
Publisher
Springer Nature
Online
2017-12-12
DOI
10.1007/s10928-017-9559-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanism-Based Competitive Binding Model to Investigate the Effect of Neonatal Fc Receptor Binding Affinity on the Pharmacokinetic of Humanized Anti-VEGF Monoclonal IgG1 Antibody in Cynomolgus Monkey
- (2016) Chee M. Ng et al. AAPS Journal
- Antibodies to watch in 2017
- (2016) Janice M. Reichert mAbs
- A Bottom-Up Whole-Body Physiologically Based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins
- (2015) Katherine L. Gill et al. AAPS Journal
- Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective
- (2015) HM Jones et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Systematic Evaluation of the Use of Physiologically Based Pharmacokinetic Modeling for Cross-Species Extrapolation
- (2015) Christoph Thiel et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Development of a physiologically based pharmacokinetic model for a domain antibody in mice using the two-pore theory
- (2015) Armin Sepp et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptide
- (2015) Elliot Offman et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development
- (2015) Aman P. Singh et al. PHARMACEUTICAL RESEARCH
- Prediction of the Pharmacokinetics, Pharmacodynamics, and Efficacy of a Monoclonal Antibody, Using a Physiologically Based Pharmacokinetic FcRn Model
- (2015) Manoranjenni Chetty et al. Frontiers in Immunology
- Biologics: An Update and Challenge of Their Pharmacokinetics
- (2014) Shaojun Shi CURRENT DRUG METABOLISM
- Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models
- (2014) Ludivine Fronton et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Characterization and screening of IgG binding to the neonatal Fc receptor
- (2014) Tobias Neuber et al. mAbs
- Quantitative cumulative biodistribution of antibodies in mice
- (2014) Victor Yip et al. mAbs
- Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody
- (2014) Kenta Haraya et al. XENOBIOTICA
- Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
- (2013) Brian Gurbaxani et al. MOLECULAR IMMUNOLOGY
- Physiology of Blood–Brain Interfaces in Relation to Brain Disposition of Small Compounds and Macromolecules
- (2013) N. Strazielle et al. MOLECULAR PHARMACEUTICS
- Evaluation of a Catenary PBPK Model for Predicting the In Vivo Disposition of mAbs Engineered for High-Affinity Binding to FcRn
- (2012) Yang Chen et al. AAPS Journal
- Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches
- (2012) Hannah M. Jones et al. AAPS Journal
- Investigation of the Role of FcγR and FcRn in mAb Distribution to the Brain
- (2012) Lubna Abuqayyas et al. MOLECULAR PHARMACEUTICS
- Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
- (2011) Malcolm Rowland et al. Annual Review of Pharmacology and Toxicology
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, Part 1: Oral solutions
- (2011) Kirstin Thelen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
- (2011) Dhaval K. Shah et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Therapeutic Mechanism and Efficacy of the Antibody-Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9
- (2011) H. M. Petrul et al. MOLECULAR CANCER THERAPEUTICS
- A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks
- (2011) Thomas Eissing Frontiers in Physiology
- Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor- Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
- (2010) R. Deng et al. DRUG METABOLISM AND DISPOSITION
- Investigation of the Influence of FcRn on the Distribution of IgG to the Brain
- (2009) Amit Garg et al. AAPS Journal
- Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic–pharmacodynamic modeling of biologics
- (2009) Leonid Gibiansky et al. Expert Opinion on Drug Metabolism & Toxicology
- Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
- (2009) Y. A. Yeung et al. JOURNAL OF IMMUNOLOGY
- Physiologically based pharmacokinetic model for T84.66: A monoclonal anti-CEA antibody
- (2009) Shweta R. Urva et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn
- (2009) Kristi Baker et al. Seminars in Immunopathology
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
- (2008) Andrea N Edginton et al. Expert Opinion on Drug Metabolism & Toxicology
- Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A
- (2008) Claribel P. Taylor et al. VACCINE
- Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
- (2007) B.J. Anderson et al. Annual Review of Pharmacology and Toxicology
- A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs
- (2007) Jasmine P. Davda et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
- General approach for the calculation of tissue to plasma partition coefficients
- (2007) Walter Schmitt TOXICOLOGY IN VITRO
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started